MIRA INFORM REPORT

 

 

Report No. :

356242

Report Date :

22.12.2015

 

IDENTIFICATION DETAILS

 

Name :

ZUVENTUS HEALTHCARE LIMITED

 

 

Registered Office :

Emcure House, T-184, M.I.D.C., Bhosari, Pune – 411026, Maharashtra

Tel. No.:

91-22-30610000

 

 

Country :

India

 

 

Financials (as on) :

31.03.2015

 

 

Date of Incorporation :

27.05.2002

 

 

Com. Reg. No.:

11-018324

 

 

Capital Investment / Paid-up Capital :

Rs.200.552 Million

 

 

CIN No.:

[Company Identification No.]

U85320PN2002PLC018324

 

 

IEC No.:

3105001191

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AAACZ1513C

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Subject is engaged in Trading and Manufacturing of Pharmaceuticals formulations. (Registered Activity)

 

 

No. of Employees :

Information declined by the management

 

 

RATING & COMMENTS

 

MIRA’s Rating :

A (56)

 

RATING

STATUS

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a part of the Emcure group based out of Pune. Emcure Pharmaceuticals, the flagship company of the group holds 79.58% stake in the subject company. It was incorporated in the year 2002 and has fine track. It is a manufacturer, trader and Importer of Pharmaceuticals Products.

 

Rating takes into consideration strong financial risk profile of the company marked by adequate networth base and comfortable gearing in FY 15. Further, the company has reported decent increase in its net profit in the year under consideration.

 

Trade relations are fair. Business is active. Payment terms are reported to be usually correct.

 

In view of long track record of business operations along with decent financial condition, the company can be considered for business dealings with usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

 

 

EXTERNAL AGENCY RATING

 

 

Rating Agency Name

CARE

Rating

Long Term Bank Facilities=A+

Rating Explanation

Adequate degree of safety and low credit risk.

Date

10.10.2014

 

Rating Agency Name

CARE

Rating

Short Term Bank Facilities=A1

Rating Explanation

Very strong degree of safety and carry lowest credit risk.

Date

10.10.2014

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2015.

 

 

INFORMATION DENIED

 

MANAGEMENT NON-COOPERATIVE (Tel No.: 91-22-30610000)

 

 

LOCATIONS

 

Registered Office :

Emcure House, T-184, M.I.D.C., Bhosari, Pune – 411026, Maharashtra, India

Tel. No.:

91-20-24117700/ 27120084/ 30610000

Fax No.:

91-20-24117111

E-Mail :

zuventus.corporate@zuventus.com

commercial@zuventus.com

productcomplaints@zuventus.com

medico@zuventus.com

legal@zuventus.com

hrd@zuventus.com

Website :

http://www.zuventus.co.in

 

 

Head Office :

Office No. 5119, 5th Floor, 'D' Wing, Oberoi Garden Estates, Chandivili, Andheri (East), Mumbai - 400 072, Maharashtra, India

Tel. No.:

91-22-30610000 / 28472823 / 24

Fax No.:

91-22-28472828 / 29

 

 

Warehouse 1 :

Block No. 146/1, Village Mann, Taluka Mulshi Post, Hinjewadi, Pune – 411057, Maharashtra, India

 

 

Warehouse 2 :

Also Located at

 

  • Jammu Kashmir

 

 

DIRECTORS

 

As on 31.03.2015

 

Name :

Mr. Prakash Kumar Guha

Designation :

Managing Director

Address :

Bldg No.B4, Flat No. 505 Raunak Park, Konkani Pada, Pokharan Road No,2, Thane – 400608, Maharashtra, India

Date of Birth/Age :

27.03.1964

Qualification :

B.SC,MBA, LLB

Date of Appointment :

27.05.2002

DIN No.:

00118415

PAN No.:

ADPPG2715G

 

 

Name :

Mr. Arunkumar Purshotamlal Khanna

Designation :

Director

Address :

Clover Hills, Bungalow No.63, Nibn Road, Kondhwa, Pune – 411048, Maharashtra, India

Date of Birth/Age :

09.07.1952

Qualification :

B.SC., M.A. (Economics)

Date of Appointment :

03.07.2002

DIN No.:

00121686

PAN No.:

AGIPK3043K

 

 

Name :

Mr. Hitesh Sohanlal Jain

Designation :

Director

Address :

Alka CHS, B. Road, Flat No.13, 2nd Floor, 40 Marine Drive, Mumbai – 400020, Maharashtra, India

Date of Birth/Age :

20.10.1973

Qualification :

LLM

Date of Appointment :

18.05.2009

DIN No.:

00130023

 

 

Name :

Mrs. Namita Vikas Thapar

Designation :

Director

Address :

Prasanna, 4, Mumbai Pune Road, Kirkee, Pune – 411003, Maharashtra, India 

Date of Birth/Age :

21.03.1977

Qualification :

B.Com, CA, MBA

Date of Appointment :

03.07.2012

DIN No.:

05318899

 

 

Name :

Mr. Vikas Madan Thapar

Designation :

Director

Address :

Prasanna 4, Mumbai-Pune Road, Pune – 411003, Maharashtra, India 

Date of Birth/Age :

27.04.1974

Date of Appointment :

18.05.2009

DIN No.:

02617012

PAN No.:

AFAPT2051D

 

 

Name :

Mr. Sanjay Rajnikant Mehta

Designation :

Director

Address :

4, Mumbai Pune Road, Kirkee, Pune – 411003, Maharashtra, India 

Date of Birth/Age :

18.04.1964

Qualification :

B.COM.

Date of Appointment :

22.08.2006

DIN No.:

00100228

PAN No.:

AAUPM2924M

 

 

Name :

Mr. Shreekant Krushnaji Bapat

Designation :

Director

Address :

Yashodhan, 2 No. Floor, 56 United Western CHS, Karve Nagar, Pune - 411052, Maharashtra, India 

Date of Birth/Age :

06.10.1937

Qualification :

Indian Police Service (Retired)

Date of Appointment :

03.07.2002

DIN No.:

00621568

 

 

Name :

Mr. Satish Ramanlal Mehta

Designation :

Director

Address :

4, Mumbai Pune Road, Kirkee, Pune – 411003, Maharashtra, India 

Date of Birth/Age :

13.01.1951

Date of Appointment :

03.07.2002

DIN No.:

00118691

PAN No.:

AAVPM4447J

 

 

KEY EXECUTIVES

 

Name :

Ms. Shilpa Uday Dhavale

Designation :

Secretary

Address :

C 302, Sai Marigold Society, Pimple Saudagar, Pune - 411028, Maharashtra, India

Date of Appointment :

29.06.2015

PAN No.:

ATIPD0060E

 

 

Name :

Mr. Raju Pessumal Kalera

Designation :

Chief Financial Officer

Address :

Building C1 Flat No. 202, SND 592a, CTS 3336, Mandke Advantage Homes, Lullanagar, Pune - 411040, Maharashtra, India

Date of Appointment :

01.11.2014

PAN No.:

AGOPK9902F

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 31.03.2015

 

Names of Shareholders

No. of Shares

% Holding

Prakashkumar Prasanta Guha

2511000

12.52

Shriram Balasubramaniam

300000

1.50

Chandrakant Vittal Shetty

300000

1.50

Satish Ramanlal Mehta

52560

0.26

A.K. Khanna

10500

0.05

Sunil Rajanikant Mehta

10560

0.05

Sanjay Rajanikant Mehta

10560

0.04

Emcure Pharmaceuticals Limited, India

15960000

79.58

Michael Mascarenhas

300000

1.50

Roony Jena

300000

1.50

Kamal Kapoor

300000

1.50

Total

20055180

100.00

 

 

As on 28.07.2014

 

Category

Percentage

Bodies corporate

79.58

Directors or relatives of Directors

12.17

Other top fifty shareholders

8.25

Total

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Subject is engaged in Trading and Manufacturing of Pharmaceuticals formulations. (Registered Activity)

 

 

Products :

Item Code No.

Product Description

30045020

Medicament

(Pharmaceutical products)

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

Not Divulged

 

 

PRODUCTION STATUS NOT AVAILABLE

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark:

Not Divulged

 

 

Customers :

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark:

Not Divulged

 

 

No. of Employees :

Information declined by the management

 

 

Bankers :

Bank Name

CITI Bank N. A.

Branch

2413, Kumar Capital, East Street, Pune - 411001, Maharashtra, India

Person Name (With Designation)

Not Divulged

Contact Number

Not Divulged

Name of Account Holder

Not Divulged

Account Number

Not Divulged

Account Since (Date/Year of Account Opening)

Not Divulged

Average Balance Maintained (If Possible)

Not Divulged

Credit Facilities Enjoyed (If any)

Not Divulged

Account Operation

Not Divulged

Remarks (If any)

Not Divulged

 

 

Facilities :

Secured Loan

31.03.2015

(Rs. in Million)

31.03.2014

(Rs. in Million)

Long-term Borrowings

 

 

Term loans from banks

0.000

0.240

 

 

 

Short-term borrowings

 

 

Loans repayable on demand

113.362

7.006

 

 

 

Total

113.362

7.246

 

 

 

Auditors :

 

Name :

Price Waterhouse

Chartered Accountants

Address :

7th Floor, Business Bay, Tower A, Wing-1, Airport Road, Yerwada, Pune – 411006, Maharashtra, India

PAN N Income-tax PAN of auditor or auditor's firm :

AAEFP3641G

 

 

Memberships :

--

 

 

Collaborators :

--

 

 

Holding Company :

Emcure Pharmaceuticals Limited, India (U24231PN1981PLC024251)

 

 

Subsidiary Company :

Gennova Biopharmaceuticals Limited, India (U24231PN2001PLC016253)

 

 

Other Related Party:

H.M. Sales Corporation, India

 

 

CAPITAL STRUCTURE

 

As on 31.03.2015

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

25000000

Equity Shares

Rs.10/- each

Rs.250.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

20055180

Equity Shares

Rs.10/- each

Rs.200.552 Million

 

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

31.03.2015

31.03.2014

31.03.2013

 

 

 

 

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

200.552

50.138

50.138

(b) Reserves & Surplus

1417.515

1349.952

1189.785

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

1618.067

1400.090

1239.923

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

0.000

0.240

29.827

(b) Deferred tax liabilities (Net)

0.000

4.588

3.287

(c) Other long term liabilities

28.450

23.450

24.350

(d) long-term provisions

39.621

24.820

28.147

Total Non-current Liabilities (3)

68.071

53.098

85.612

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

113.362

7.006

222.412

(b) Trade payables

339.112

282.769

288.990

(c) Other current liabilities

150.037

231.200

240.789

(d) Short-term provisions

196.163

168.931

99.490

Total Current Liabilities (4)

798.674

689.907

851.682

 

 

 

 

TOTAL

2484.812

2143.095

2177.216

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

445.207

435.075

440.796

(ii) Intangible Assets

1.027

1.150

2.367

(iii) Capital work-in-progress

17.867

0.000

3.055

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

450.407

150.407

150.407

(c) Deferred tax assets (net)

0.658

0.000

0.000

(d)  Long-term Loan and Advances

101.883

70.213

76.360

(e) Other Non-current assets

4.015

2.743

2.244

Total Non-Current Assets

1021.064

659.588

675.228

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

671.094

609.596

480.821

(c) Trade receivables

579.297

554.934

840.387

(d) Cash and cash equivalents

113.783

204.149

58.086

(e) Short-term loans and advances

96.372

111.767

121.782

(f) Other current assets

3.202

3.060

0.912

Total Current Assets

1463.748

1483.506

1501.988

 

 

 

 

TOTAL

2484.812

2143.095

2177.216

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2015

31.03.2014

31.03.2013

 

SALES

 

 

 

 

Income

5540.197

4500.070

4257.308

 

Other Income

4.999

2.481

2.049

 

TOTAL (A)

5545.196

4502.551

4259.357

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

616.184

513.979

488.636

 

Purchases of Stock-in-Trade

1836.226

1642.357

1353.887

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(11.063)

(118.706)

(58.027)

 

Employees benefits expense

983.225

850.592

806.425

 

Other expenses

1391.126

1235.279

1181.059

 

CSR Expenditure

1.936

0.000

0.000

 

TOTAL (B)

4817.634

4123.501

3771.980

 

 

 

 

 

Less

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (C)

727.562

379.050

487.377

 

 

 

 

 

Less

FINANCIAL EXPENSES (D)

13.510

27.433

36.972

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E)

714.052

351.617

450.405

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION (F)

53.337

28.476

30.894

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX (E-F)   (G)

660.715

323.141

419.511

 

 

 

 

 

Less

TAX (H)

201.906

104.315

121.037

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX  (G-H)   (I)

458.809

218.826

298.474

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD  (K)

1037.870

899.584

660.290

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

Transfer to General Reserve

180.480

21.880

29.850

 

Final Dividend

60.349

58.660

29.330

 

Total (M)

240.829

80.540

59.180

 

 

 

 

 

 

Balance Carried to the B/S (J+K+L-M)

1255.850

1037.870

899.584

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

22.88

10.91

59.53

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2015

31.03.2014

31.03.2013

Current Maturities of Long term debt

0.240

26.587

37.500

Cash generated from operations

NA

NA

NA

Net cash flows from (used in) operations

664.802

553.849

185.308

Net cash flow from operating activity

453.162

445.573

79.269

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2015

31.03.2014

31.03.2013

Net Profit Margin

(PAT / Sales)

(%)

8.28

4.86

7.01

 

 

 

 

 

Operating Profit Margin

(PBIDT/Sales)

(%)

13.13

8.42

11.45

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

32.78

16.22

20.73

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.41

0.23

0.34

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.07

0.02

0.23

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.83

2.15

1.76

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

50.138

50.138

200.552

Reserves & Surplus

1189.785

1349.952

1417.515

Money received against share warrants

0.000

0.000

0.000

 Share Application money pending allotment

0.000

0.000

0.000

Net worth

1239.923

1400.090

1618.067

 

 

 

 

long-term borrowings

29.827

0.240

0.000

Short term borrowings

222.412

7.006

113.362

Current Maturities of Long-Term Debts

37.500

26.587

0.240

Total borrowings

289.739

33.833

113.602

Debt/Equity ratio

0.234

0.024

0.070

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

4257.308

4500.070

5540.197

 

 

5.702

23.114

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

4257.308

4500.070

5540.197

Profit

298.474

218.826

458.809

 

7.01%

4.86%

8.28%

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

No

8

Designation of contact person

No

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

Yes

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

No

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

Yes

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

No

35

Negative Reporting by Auditors in the Annual Report

No

 

GENERAL INFORMATION

 

The Company, a limited company is engaged in trading and manufacturing of Pharmaceuticals formulations. The Company has its own manufacturing plant at Jammu. The Company has several clearing and forwarding agents in various cities in India to ensure timely supply of its products in the various parts of the country.

 

RESULT OF OPERATIONS

 

The Company has recorded a growth in its Revenue for the thirteenth year in succession. Gross Revenue from Operations for the year are Rs. 5654.720 million as compared to the previous years Rs. 4587.800 million thus recording a growth of 23.26%.

 

 

INDEX OF CHARGES

 

S.No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10578871

01/06/2015

165,000,000.00

Citi Bank N.A.

First International Financial Centre,Plot No C-54, and C-55, G-Block, Bandra Kurla Complex, Bandra East, Mumbai, Maharashtra - 400051, INDIA

C58301839

2

10225051

01/06/2010

150,000,000.00

State Bank of India Industrial Finance Branch

Tara Chamber,2nd Floor,Near Mariaai Police Chowky, 
Pune-Mumbai Highway,Wakdewadi, Pune, Maharashtra - 411003, INDIA

A88045109

3

10216083

09/02/2012 *

450,000,000.00

State Bank of India Industrial Finance Branch

Tara Chamber, 2nd Floor,Near Mariaai Police Chowky, Pune-Mumbai Highway,Wakdewadi, Pune, Maharashtra 
- 411003, INDIA

B35612266

 

 

FIXED ASSETS

 

  • Land
  • Buildings
  • Plant and equipment
  • Factory equipments
  • Furniture and fixtures
  • Vehicles
  • Office equipment
  • Computer equipments
  • Other equipments

 

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                                       None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.66.32

UK Pound

1

Rs.98.98

Euro

1

Rs.72.13

 

 

INFORMATION DETAILS

 

Information Gathered by :

GYA

 

 

Analysis Done by :

KIN

 

 

Report Prepared by :

SUD


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

7

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILITY

1~10

7

--LIQUIDITY

1~10

6

--LEVERAGE

1~10

6

--RESERVES

1~10

6

--CREDIT LINES

1~10

6

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

56

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.